Tekla Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-418,520
| Closed | -$9.41M | – | 181 |
|
2023
Q1 | $9.41M | Hold |
418,520
| – | – | 0.36% | 58 |
|
2022
Q4 | $8.8M | Buy |
418,520
+170,842
| +69% | +$3.59M | 0.33% | 60 |
|
2022
Q3 | $6.1M | Hold |
247,678
| – | – | 0.25% | 71 |
|
2022
Q2 | $6M | Hold |
247,678
| – | – | 0.24% | 81 |
|
2022
Q1 | $6.38M | Buy |
247,678
+34,809
| +16% | +$897K | 0.22% | 84 |
|
2021
Q4 | $6.61M | Hold |
212,869
| – | – | 0.21% | 89 |
|
2021
Q3 | $5.16M | Hold |
212,869
| – | – | 0.17% | 105 |
|
2021
Q2 | $3.11M | Hold |
212,869
| – | – | 0.1% | 141 |
|
2021
Q1 | $5.32M | Buy |
+212,869
| New | +$5.32M | 0.18% | 113 |
|
2017
Q3 | – | Sell |
-167,949
| Closed | -$3.26M | – | 160 |
|
2017
Q2 | $3.26M | Hold |
167,949
| – | – | 0.12% | 97 |
|
2017
Q1 | $3.1M | Hold |
167,949
| – | – | 0.12% | 95 |
|
2016
Q4 | $3.18M | Sell |
167,949
-162,000
| -49% | -$3.07M | 0.14% | 88 |
|
2016
Q3 | $7.38M | Hold |
329,949
| – | – | 0.28% | 72 |
|
2016
Q2 | $5.88M | Hold |
329,949
| – | – | 0.24% | 80 |
|
2016
Q1 | $4.51M | Hold |
329,949
| – | – | 0.19% | 92 |
|
2015
Q4 | $6.37M | Buy |
+329,949
| New | +$6.37M | 0.23% | 81 |
|